Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine for early treatment of severe acute pancreatitis
ChiCTR2300071143Phase 4Recruiting
- Sponsor
- Department of Critical Care Medicine, the Second Affiliated Hospital of Anhui Medical University
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine, sponsored by Department of Critical Care Medicine, the Second Affiliated Hospital of Anhui Medical University. Started Apr 2023; status: recruiting.
02
Drugs
nalbuphine
Beyond the preview
Go deeper on ChiCTR2300071143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071143.